| Literature DB >> 30836111 |
Paulo Eduardo Orlandi-Mattos1, Rodrigo Barbosa Aguiar1, Itabajara da Silva Vaz2, Jane Zveiter Moraes3, Elisaldo Luiz de Araujo Carlini4, Maria Aparecida Juliano1, Luiz Juliano5.
Abstract
Stem bromelain [EC 3.4.22.32] is a thiol-endopeptidase and orally recommended in traditional medicine due to its analgesic activity, but the mechanisms are not known. Proenkephalin is expressed in the nervous system, but also in the gastrointestinal tract, where it can be assessed by ingested stem bromelain. Here we demonstrated that stem bromelain hydrolyses synthetic proenkephalin fragments after basic amino acid residues flanking the enkephalin sequences. We also observed with in vivo studies that oral administration of bromelain reduced jejunum proenkephalin levels and increased the serum enkephalin in mice. Effective anti-nociceptive effects in mice were observed 3 h after oral administration of 3 mg/kg stem bromelain by the acetic acid-induced writhing test. However, with higher doses this effect is reduced due to hydrolysis of enkephalin that possibly occurs by the presence of ananain in commercial pineapple stem bromelain preparations, that is also a thiol-protease with broad specificity. The analgesic effects were also evaluated by hot-plate and formalin tests and the obtained results indicated that enkephalin generated in intestine acts in periphery where it also can have anti-inflammatory activity.Entities:
Keywords: Anti-nociception; Cysteine protease; Enkephalin; Peptides; Proenkephalin; Stem bromelain
Mesh:
Substances:
Year: 2019 PMID: 30836111 DOI: 10.1016/j.peptides.2019.02.008
Source DB: PubMed Journal: Peptides ISSN: 0196-9781 Impact factor: 3.750